Medicare Enrolled
Dr. Krishna Pachipala, M.D.
Hematology & Oncology · Shenandoah, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pachipala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pachipala? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pachipala
Dr. Krishna Pachipala is a hematology & oncology in Shenandoah, TX, with 19 years in practice. Based on federal Medicare data, Dr. Pachipala performed 77,522 Medicare services across 1,500 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pachipala received a total of $25,698 from 75 pharmaceutical and/or device companies across 493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pachipala is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 12% volume in TX$ $25,698 industry payments
Medicare Practice Summary
Medicare Utilization ↗77,522
Medicare services
Top 12% in TX for hematology & oncology
1,500
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,080 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 32,600 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia | 16,090 | $2 | $8 |
| Contrast dye for imaging (iodine-based) | 8,900 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) | 8,550 | $0 | $1 |
| MRI contrast dye injection (gadoterate) | 4,400 | $0 | $0 |
| Dexamethasone injection (steroid) | 1,732 | $0 | $0 |
| Anti-nausea injection (Aloxi/palonosetron) | 920 | $1 | $6 |
| Office visit, established patient (30-39 min) | 915 | $89 | $345 |
| Flow cytometry, additional marker | 526 | $19 | $62 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 474 | $22 | $82 |
| Drug injection, under skin or into muscle | 380 | $11 | $38 |
| Administration of chemotherapy into vein, 1 hour or less | 249 | $99 | $375 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 201 | $47 | $179 |
| Hospital follow-up visit, moderate complexity | 196 | $58 | $198 |
| Office visit, established patient (20-29 min) | 181 | $64 | $248 |
| Administration of chemotherapy into vein, each additional hour | 160 | $22 | $80 |
| Office visit, established patient, complex (40-54 min) | 152 | $127 | $477 |
| Administration of additional new drug or substance into vein, 1 hour or less | 89 | $49 | $183 |
| Irrigation of implanted venous access drug delivery device | 86 | $19 | $73 |
| Injection, diphenhydramine hcl, up to 50 mg | 82 | $1 | $3 |
| Ct scan of chest with contrast | 81 | $51 | $433 |
| New patient office visit (45-59 min) | 77 | $122 | $451 |
| CT scan of abdomen and pelvis with contrast | 70 | $152 | $812 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 62 | $1,142 | $5,764 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 57 | $110 | $295 |
| Hospital follow-up visit, high complexity | 56 | $89 | $285 |
| Initial hospital admission, moderate complexity | 53 | $100 | $357 |
| Drawing of blood for a medical problem | 44 | $71 | $276 |
| CT scan of chest, without contrast | 29 | $54 | $331 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $17 | $62 |
| Flow cytometry technique for dna or cell analysis, first marker | 22 | $55 | $190 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 18 | $73 | $300 |
| Complete ultrasound scan of abdomen | 14 | $57 | $306 |
| New patient office visit, complex (60-74 min) | 14 | $156 | $587 |
| Initial hospital admission, high complexity | 14 | $125 | $502 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
95.9% medium
3.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$25,698
Total received (2018-2024)
Avg $3,671/year across 7 years
Top 18% in TX for hematology & oncology
75
Companies
493
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$13,093 (50.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,011 (31.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,594 (17.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$573
2023$1,976
2022$1,863
2021$7,171
2020$6,954
2019$1,901
2018$5,261
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$6,251
Genentech USA, Inc.
$4,231
ARRAY BIOPHARMA INC
$2,491
AstraZeneca Pharmaceuticals LP
$2,276
G1 Therapeutics, Inc.
$1,539
R-Pharm US LLC
$1,353
PFIZER INC.
$693
Amgen Inc.
$669
E.R. Squibb & Sons, L.L.C.
$603
Janssen Biotech, Inc.
$533
Seagen Inc.
$481
GlaxoSmithKline, LLC.
$381
Astellas Pharma US Inc
$311
Celgene Corporation
$224
Merck Sharp & Dohme Corporation
$205
Pharmacyclics LLC, An AbbVie Company
$205
Eisai Inc.
$202
Gilead Sciences, Inc.
$194
GENZYME CORPORATION
$180
Karyopharm Therapeutics Inc.
$170
BeiGene USA, Inc.
$161
Foundation Medicine, Inc.
$152
Takeda Pharmaceuticals U.S.A., Inc.
$145
EISAI INC.
$114
Janssen Pharmaceuticals, Inc
$109
Aurinia Pharma U.S., Inc.
$104
Dendreon Pharmaceuticals LLC
$100
PUMA BIOTECHNOLOGY, INC.
$94
AVEO Pharmaceuticals, Inc.
$89
MorphoSys, US Inc.
$84
Daiichi Sankyo Inc.
$78
Puma Biotechnology, Inc.
$75
Incyte Corporation
$71
Spectrum Pharmaceuticals Inc.
$66
Aveo Pharmaceuticals, Inc.
$61
CTI BioPharma Corp.
$54
Exelixis Inc.
$54
ADC Therapeutics America, Inc.
$48
ABBVIE INC.
$44
AbbVie Inc.
$41
Aurobindo Pharma USA, Inc.
$40
MEDIVATION FIELD SOLUTIONS LLC
$39
JAZZ PHARMACEUTICALS INC.
$39
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
Otsuka America Pharmaceutical, Inc.
$34
Bayer HealthCare Pharmaceuticals Inc.
$31
Kite Pharma, Inc.
$30
Sumitomo Pharma America, Inc.
$28
Immunomedics, Inc.
$28
SOBI, INC
$28
Bayer Healthcare Pharmaceuticals Inc.
$27
Pharmacosmos Therapeutics Inc.
$25
SANOFI-AVENTIS U.S. LLC
$25
Alexion Pharmaceuticals, Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
SpringWorks Therapeutics, Inc.
$22
Blueprint Medicines Corporation
$20
Teva Pharmaceuticals USA, Inc.
$20
Taiho Oncology, Inc.
$18
Dova Pharmaceuticals
$18
Clovis Oncology, Inc.
$16
Covidien LP
$16
Sirtex Medical Inc
$16
AbbVie, Inc.
$15
Stemline Therapeutics Inc.
$15
TerSera Therapeutics LLC
$15
Merck Sharp & Dohme LLC
$14
Heron Therapeutics, Inc.
$14
Ipsen Biopharmaceuticals, Inc
$14
Octapharma USA, Inc.
$13
Sobi, Inc
$13
Lilly USA, LLC
$13
Agios Pharmaceuticals, Inc.
$12
Seattle Genetics, Inc.
$12
AMAG Pharmaceuticals, Inc.
$12
Top 3 companies account for 50.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AVYCAZ · AYVAKIT · Abraxane · Avastin · BENDEKA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Creon · DARZALEX · DOPTELET · Doptelet · ELIQUIS · EMEND · EMPLICITI · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMFINZI · INJECTAFER · INLYTA · INQOVI · Imbruvica · Ixempra · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUPKYNIS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PIQRAY · PROMACTA · PROVENGE · Perjeta · Pomalyst · REBLOZYL · RYDAPT · Rituxan · Rubraca · SCEMBLIX · SIMPONI ARIA · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SuperDimension · TAGRISSO · TECENTRIQ · TIBSOVO · Tavalisse · Trodelvy · VENCLEXTA · VOTRIENT · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · ZEPZELCA · Zevalin · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $33 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
27
Per 100K population
4.1
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pachipala is a mixed practice specialist, with above-average Medicare volume (top 12% in TX), and high industry engagement (consulting-driven, top 18%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pachipala experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Pachipala performed 32,600 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pachipala receive payments from pharmaceutical companies?
Yes. Dr. Pachipala received a total of $25,698 from 75 companies across 493 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pachipala's costs compare to other hematology & oncologys in Shenandoah?
Dr. Pachipala's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pachipala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Shenandoah
Browse hematology & oncologys in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc..
By company
ARRAY BIOPHARMA INC Payments to Doctors
See all physicians who received payments from ARRAY BIOPHARMA INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology